Skip to Content

Canopus Biopharma Inc CBIA

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Canopus Biopharma Inc is a bio-pharmaceutical company. The Company is engaged in the development and commercialization of drugs that address unmet medical needs & for patients suffering from infectious disease, bioterrorism, cancer and addiction.

Contact
233 Wilshire Boulevard, Suite 700
Santa Monica, CA, 90401
T +1 310 566-8148
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Fiscal Year End Jun 30, 2015
Stock Type
Employees